Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Letters

Volume 28—2022

Volume 28, Number 6—June 2022

Cover of issue Volume 28, Number 6—June 2022

Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020 [PDF - 510 KB - 2 pages]
K. X. McNamara et al.
EID McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerg Infect Dis. 2022;28(6):1303. https://doi.org/10.3201/eid2806.220520
AMA McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases. 2022;28(6):1303. doi:10.3201/eid2806.220520.
APA McNamara, K. X., Perz, J. F., & Perkins, K. M. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases, 28(6), 1303. https://doi.org/10.3201/eid2806.220520.

Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response) [PDF - 510 KB - 2 pages]
C. Daniau et al.
EID Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerg Infect Dis. 2022;28(6):1303-1304. https://doi.org/10.3201/eid2806.220686
AMA Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases. 2022;28(6):1303-1304. doi:10.3201/eid2806.220686.
APA Daniau, C., Berger-Carbonne, A., & Cambau, E. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases, 28(6), 1303-1304. https://doi.org/10.3201/eid2806.220686.

Volume 28, Number 5—May 2022

Cover of issue Volume 28, Number 5—May 2022

Guillain-Barré Syndrome Associated with COVID-19 Vaccination [PDF - 237 KB - 2 pages]
J. Finsterer et al.
EID Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerg Infect Dis. 2022;28(5):1079-1080. https://doi.org/10.3201/eid2805.212145
AMA Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases. 2022;28(5):1079-1080. doi:10.3201/eid2805.212145.
APA Finsterer, J., Scorza, F. A., & Scorza, C. A. (2022). Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases, 28(5), 1079-1080. https://doi.org/10.3201/eid2805.212145.

SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia [PDF - 237 KB - 2 pages]
J. T. Grassia et al.
EID Grassia JT, Markwalter CF, O’Meara WP, Taylor SM, Obala AA. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerg Infect Dis. 2022;28(5):1080-1081. https://doi.org/10.3201/eid2805.220404
AMA Grassia JT, Markwalter CF, O’Meara WP, et al. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases. 2022;28(5):1080-1081. doi:10.3201/eid2805.220404.
APA Grassia, J. T., Markwalter, C. F., O’Meara, W. P., Taylor, S. M., & Obala, A. A. (2022). SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases, 28(5), 1080-1081. https://doi.org/10.3201/eid2805.220404.

Melioidosis in Children, Brazil, 1989–2019 [PDF - 237 KB - 2 pages]
B. Behera et al.
EID Behera B, Radhakrishnan A, Mohapatra S, Mishra B. Melioidosis in Children, Brazil, 1989–2019. Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.211473
AMA Behera B, Radhakrishnan A, Mohapatra S, et al. Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.211473.
APA Behera, B., Radhakrishnan, A., Mohapatra, S., & Mishra, B. (2022). Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.211473.

Melioidosis in Children, Brazil, 1989–2019 (response) [PDF - 212 KB - 1 page]
R. Lima and D. Rolim
EID Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.220479
AMA Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.220479.
APA Lima, R., & Rolim, D. (2022). Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.220479.

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 [PDF - 197 KB - 1 page]
D. Focosi and A. Casadevall
EID Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerg Infect Dis. 2022;28(5):1083. https://doi.org/10.3201/eid2805.220191
AMA Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases. 2022;28(5):1083. doi:10.3201/eid2805.220191.
APA Focosi, D., & Casadevall, A. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases, 28(5), 1083. https://doi.org/10.3201/eid2805.220191.

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response) [PDF - 206 KB - 2 pages]
G. C. De Santis and R. T. Calado
EID De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerg Infect Dis. 2022;28(5):1083-1084. https://doi.org/10.3201/eid2805.220363
AMA De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases. 2022;28(5):1083-1084. doi:10.3201/eid2805.220363.
APA De Santis, G. C., & Calado, R. T. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases, 28(5), 1083-1084. https://doi.org/10.3201/eid2805.220363.

Volume 28, Number 3—March 2022

Cover of issue Volume 28, Number 3—March 2022

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level [PDF - 691 KB - 1 page]
I. G. Barr et al.
EID Barr IG, Williams TC, Salimi V, Buchholz UJ. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis. 2022;28(3):764. https://doi.org/10.3201/eid2803.212438
AMA Barr IG, Williams TC, Salimi V, et al. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases. 2022;28(3):764. doi:10.3201/eid2803.212438.
APA Barr, I. G., Williams, T. C., Salimi, V., & Buchholz, U. J. (2022). Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases, 28(3), 764. https://doi.org/10.3201/eid2803.212438.

Volume 28, Number 2—February 2022

Cover of issue Volume 28, Number 2—February 2022

High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh [PDF - 1.01 MB - 2 pages]
S. T. Hegde et al.
EID Hegde ST, Bhuiyan T, Akhtar M, Islam T, Hulse J, Khan Z, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerg Infect Dis. 2022;28(2):491-492. https://doi.org/10.3201/eid2802.212417
AMA Hegde ST, Bhuiyan T, Akhtar M, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases. 2022;28(2):491-492. doi:10.3201/eid2802.212417.
APA Hegde, S. T., Bhuiyan, T., Akhtar, M., Islam, T., Hulse, J., Khan, Z....Qadri, F. (2022). High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases, 28(2), 491-492. https://doi.org/10.3201/eid2802.212417.

Predictors of Nonseroconversion after SARS-CoV-2 Infection [PDF - 618 KB - 2 pages]
B. Davido et al.
EID Davido B, Jaffal K, Annane D, Lawrence C, Gault E, De P. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerg Infect Dis. 2022;28(2):492-493. https://doi.org/10.3201/eid2802.211971
AMA Davido B, Jaffal K, Annane D, et al. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases. 2022;28(2):492-493. doi:10.3201/eid2802.211971.
APA Davido, B., Jaffal, K., Annane, D., Lawrence, C., Gault, E., & De, P. (2022). Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases, 28(2), 492-493. https://doi.org/10.3201/eid2802.211971.

Volume 28, Number 1—January 2022

Cover of issue Volume 28, Number 1—January 2022

New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria [PDF - 653 KB - 1 page]
Y. Yao et al.
EID Yao Y, Imirzalioglu C, Falgenhauer L, Chakraborty T. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerg Infect Dis. 2022;28(1):265. https://doi.org/10.3201/eid2801.212106
AMA Yao Y, Imirzalioglu C, Falgenhauer L, et al. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases. 2022;28(1):265. doi:10.3201/eid2801.212106.
APA Yao, Y., Imirzalioglu, C., Falgenhauer, L., & Chakraborty, T. (2022). New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases, 28(1), 265. https://doi.org/10.3201/eid2801.212106.
Page created: December 03, 2021
Page updated: May 31, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Coronavirus Spotlight

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external